ATE12778T1 - Deka-, undeka-, dodeka- und tridekapeptide mit thymischer taetigkeit, verfahren zu deren herstellung und diese enthaltende zusammensetzungen. - Google Patents
Deka-, undeka-, dodeka- und tridekapeptide mit thymischer taetigkeit, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.Info
- Publication number
- ATE12778T1 ATE12778T1 AT81305995T AT81305995T ATE12778T1 AT E12778 T1 ATE12778 T1 AT E12778T1 AT 81305995 T AT81305995 T AT 81305995T AT 81305995 T AT81305995 T AT 81305995T AT E12778 T1 ATE12778 T1 AT E12778T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- pro
- leu
- preparation
- tridecapeptids
- Prior art date
Links
- IFPMZBBHBZQTOV-UHFFFAOYSA-N 1,3,5-trinitro-2-(2,4,6-trinitrophenyl)-4-[2,4,6-trinitro-3-(2,4,6-trinitrophenyl)phenyl]benzene Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C=2C(=C(C=3C(=CC(=CC=3[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)C(=CC=2[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)=C1[N+]([O-])=O IFPMZBBHBZQTOV-UHFFFAOYSA-N 0.000 title 1
- -1 UNDEKA Chemical compound 0.000 title 1
- WHHGLZMJPXIBIX-UHFFFAOYSA-N decabromodiphenyl ether Chemical compound BrC1=C(Br)C(Br)=C(Br)C(Br)=C1OC1=C(Br)C(Br)=C(Br)C(Br)=C1Br WHHGLZMJPXIBIX-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002992 thymic effect Effects 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 abstract 1
- HATVCTYBNCNMAA-AVGNSLFASA-N Pro-Leu-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O HATVCTYBNCNMAA-AVGNSLFASA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N THREONINE Chemical compound CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 125000001288 lysyl group Chemical group 0.000 abstract 1
- 108010090894 prolylleucine Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/18—Thymus derived hormone or factor; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/218,886 US4320118A (en) | 1980-12-22 | 1980-12-22 | Deca-, undeca-, dodeca- and tridecapeptides with thymic activity |
| EP81305995A EP0055113B1 (de) | 1980-12-22 | 1981-12-21 | Deka-, Undeka-, Dodeka- und Tridekapeptide mit thymischer Tätigkeit, Verfahren zu deren Herstellung und diese enthaltende Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE12778T1 true ATE12778T1 (de) | 1985-05-15 |
Family
ID=22816887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT81305995T ATE12778T1 (de) | 1980-12-22 | 1981-12-21 | Deka-, undeka-, dodeka- und tridekapeptide mit thymischer taetigkeit, verfahren zu deren herstellung und diese enthaltende zusammensetzungen. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4320118A (de) |
| EP (1) | EP0055113B1 (de) |
| JP (1) | JPS57128666A (de) |
| KR (1) | KR830007522A (de) |
| AT (1) | ATE12778T1 (de) |
| AU (1) | AU546769B2 (de) |
| CA (1) | CA1187869A (de) |
| DE (1) | DE3170055D1 (de) |
| DK (1) | DK568281A (de) |
| FI (1) | FI77046C (de) |
| HU (1) | HU189550B (de) |
| IE (1) | IE53004B1 (de) |
| IL (1) | IL64610A (de) |
| NO (1) | NO814384L (de) |
| NZ (1) | NZ199335A (de) |
| YU (1) | YU42752B (de) |
| ZA (1) | ZA818829B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4395404A (en) * | 1982-05-14 | 1983-07-26 | George Washington University | Synthetic thymosin β3 and β4 analogues |
| CS256897B1 (en) * | 1984-12-17 | 1988-04-15 | Evzen Kasafirek | Series thymic factor's analogue-type peptides |
| US4740588A (en) * | 1986-08-07 | 1988-04-26 | Washington University | Novel substrate peptides |
| NZ226557A (en) * | 1987-10-15 | 1990-07-26 | Syntex Inc | Pharmaceutical compositions for the intranasal administration of a biologically active polypeptide in powder form and process for their preparation |
| US5786327A (en) | 1993-03-12 | 1998-07-28 | Gensci Regeneration Sciences Inc. | Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same |
| US6352973B1 (en) | 1995-06-07 | 2002-03-05 | Osteopharm Inc. | Bone stimulating factor |
| US6693081B2 (en) | 1995-09-26 | 2004-02-17 | Osteopharm Inc. | Bone stimulating factor |
| DE19724793A1 (de) * | 1997-06-06 | 1998-12-10 | Schering Ag | D-mutierte Peptide mit VEGF-Rezeptor blockierenden Eigenschaften |
| AU1589099A (en) * | 1997-11-18 | 1999-06-07 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Functionalized resin for the synthesis of amides and peptides |
| US6815421B1 (en) * | 2001-03-22 | 2004-11-09 | Osteopharm Inc. | Polypeptides for use in ameliorating effects of aging in mammals |
| GB2385415B (en) * | 2002-02-15 | 2005-09-14 | Teraview Ltd | An analysis apparatus and method |
| AU2003291871A1 (en) * | 2002-12-05 | 2004-06-23 | Osteopharm Inc. | Bone growth factor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4046877A (en) * | 1975-07-18 | 1977-09-06 | Syntex (U.S.A.) Inc. | Method of increasing immunologic competence |
-
1980
- 1980-12-22 US US06/218,886 patent/US4320118A/en not_active Expired - Fee Related
-
1981
- 1981-12-17 KR KR1019810004963A patent/KR830007522A/ko not_active Ceased
- 1981-12-21 DE DE8181305995T patent/DE3170055D1/de not_active Expired
- 1981-12-21 CA CA000392786A patent/CA1187869A/en not_active Expired
- 1981-12-21 AT AT81305995T patent/ATE12778T1/de not_active IP Right Cessation
- 1981-12-21 AU AU78705/81A patent/AU546769B2/en not_active Ceased
- 1981-12-21 NZ NZ199335A patent/NZ199335A/en unknown
- 1981-12-21 HU HU813891A patent/HU189550B/hu unknown
- 1981-12-21 YU YU3035/81A patent/YU42752B/xx unknown
- 1981-12-21 DK DK568281A patent/DK568281A/da not_active Application Discontinuation
- 1981-12-21 JP JP56205391A patent/JPS57128666A/ja active Pending
- 1981-12-21 IL IL64610A patent/IL64610A/xx unknown
- 1981-12-21 EP EP81305995A patent/EP0055113B1/de not_active Expired
- 1981-12-21 ZA ZA818829A patent/ZA818829B/xx unknown
- 1981-12-21 FI FI814112A patent/FI77046C/fi not_active IP Right Cessation
- 1981-12-21 IE IE3004/81A patent/IE53004B1/en unknown
- 1981-12-21 NO NO814384A patent/NO814384L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0055113A2 (de) | 1982-06-30 |
| FI77046C (fi) | 1989-01-10 |
| HU189550B (en) | 1986-07-28 |
| ZA818829B (en) | 1983-07-27 |
| NO814384L (no) | 1982-06-23 |
| AU7870581A (en) | 1982-07-01 |
| US4320118A (en) | 1982-03-16 |
| EP0055113A3 (en) | 1982-08-11 |
| DK568281A (da) | 1982-06-23 |
| IL64610A (en) | 1985-08-30 |
| CA1187869A (en) | 1985-05-28 |
| FI814112L (fi) | 1982-06-23 |
| DE3170055D1 (en) | 1985-05-23 |
| IE53004B1 (en) | 1988-05-11 |
| KR830007522A (ko) | 1983-10-21 |
| NZ199335A (en) | 1985-05-31 |
| JPS57128666A (en) | 1982-08-10 |
| IL64610A0 (en) | 1982-03-31 |
| FI77046B (fi) | 1988-09-30 |
| AU546769B2 (en) | 1985-09-19 |
| IE813004L (en) | 1982-06-22 |
| EP0055113B1 (de) | 1985-04-17 |
| YU303581A (en) | 1984-02-29 |
| YU42752B (en) | 1988-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO953114L (no) | Kosmetiske formuleringer med keratolytisk eller antiakneaktivitet, fremgangsmåte for fremstilling samt anvendelse derav | |
| ATE12778T1 (de) | Deka-, undeka-, dodeka- und tridekapeptide mit thymischer taetigkeit, verfahren zu deren herstellung und diese enthaltende zusammensetzungen. | |
| ES2075050T3 (es) | Peptidos que tienen actividad cooperadora de celulas t. | |
| KR880701244A (ko) | 위치 17에 스피로 고리가 있는 스테로이드, 이들의 제조 방법 및 중간체 약제로서 이들의 사용, 및 이들을 함유하는 약제학적 조성물 | |
| DE3788244D1 (de) | Pharmakologisch wirksame 3-substituierte 1,5-Diaryl-pyrazole und Verfahren zu ihrer Herstellung. | |
| AU6781187A (en) | Process for dyeing keratinous fibres with 5,6-dihydroxyindole combined with an iodine and dyeing composition employed | |
| DE69310602D1 (de) | 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität | |
| OA08481A (fr) | Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant. | |
| ES2118835T3 (es) | 2-etil-1h-imidazo(4,5-c)quinolin-4-aminas antiviricas. | |
| DE3783356D1 (de) | Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| DE3380958D1 (de) | Beta-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| DE69023947D1 (de) | Fluorierte Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus. | |
| ATE38227T1 (de) | Pharmakologisch aktive derivate von pyrido(1,5)benzodiazepinon. | |
| IE821732L (en) | Hair-dyeing composition | |
| FR2607502B1 (fr) | Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant | |
| ATE70278T1 (de) | Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und und ihre verwendung. | |
| ATE35996T1 (de) | 1alpha, 2alpha-methylen-6-methylen- und 6alphamethyl-pregnene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate. | |
| ES2179206T3 (es) | Derivados de 12h-dibenzo(d,g)(1,3)dioxocina. | |
| ES2092571T3 (es) | Compuestos heterociclicos y su preparacion y uso. | |
| PT86228A (de) | Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate | |
| DE68913411D1 (de) | Pentapeptide und Verfahren zu deren Herstellung. | |
| DE69116423D1 (de) | 3'-Deamino-4'-deoxy-4'-amino-8-fluoranthracycline und Verfahren zu ihrer Herstellung | |
| IT8722217A0 (it) | Metodo d'uso selettivo di ossabicicloalcani: | |
| DE3851325D1 (de) | Gegen den Zellmembransynthese-Inhibitor resistente Mutante und Verfahren zu deren Herstellung. | |
| ATE2897T1 (de) | 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzaz pine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |